Exploring the collaboration between antibiotics and the immune response in the treatment of acute, self-limiting infections
about
Addressing Concerns about Changing the Route of Antimicrobial Administration from Intravenous to Oral in Adult InpatientsEvolutionary rescue: linking theory for conservation and medicineIntegrating Antimicrobial Therapy with Host Immunity to Fight Drug-Resistant Infections: Classical vs. Adaptive TreatmentDoes High-Dose Antimicrobial Chemotherapy Prevent the Evolution of Resistance?A multi-scale approach to designing therapeutics for tuberculosisA model-guided analysis and perspective on the evolution and epidemiology of antibiotic resistance and its futureTackling Drug Resistant Infection Outbreaks of Global Pandemic Escherichia coli ST131 Using Evolutionary and Epidemiological Genomics.Profile of Bruce LevinPersistence: a copacetic and parsimonious hypothesis for the existence of non-inherited resistance to antibioticsAntibiotic resistance: a primer and call to actionPublic health evolutionary biology of antimicrobial resistance: priorities for interventionPharmacokinetic and pharmacodynamic considerations of antimicrobial drug therapy in cancer patients with kidney dysfunctionIs selection relevant in the evolutionary emergence of drug resistance?ClassTR: Classifying Within-Host Heterogeneity Based on Tandem Repeats with Application to Mycobacterium tuberculosis Infections.How competition governs whether moderate or aggressive treatment minimizes antibiotic resistanceHow to Use a Chemotherapeutic Agent When Resistance to It Threatens the Patient.Fosfomycin enhances phagocyte-mediated killing of Staphylococcus aureus by extracellular traps and reactive oxygen species.Diverse drug-resistant subpopulations of Mycobacterium tuberculosis are sustained in continuous culture.Measuring and modelling the response of Klebsiella pneumoniae KPC prey to Bdellovibrio bacteriovorus predation, in human serum and defined buffer.Ciprofloxacin and ceftriaxone alter cytokine responses, but not Toll-like receptors, to Salmonella infection in vitro.Mathematical Models for Immunology: Current State of the Art and Future Research Directions.Limitations of MIC as sole metric of pharmacodynamic response across the range of antimicrobial susceptibilities within a single bacterial species.The Immune Response against Acinetobacter baumannii, an Emerging Pathogen in Nosocomial Infections.Convection shapes the trade-off between antibiotic efficacy and the selection for resistance in spatial gradients.Exploiting ecology in drug pulse sequences in favour of population reductionBeyond dose: Pulsed antibiotic treatment schedules can maintain individual benefit while reducing resistance.Predicting evolution.In Vivo Pharmacokinetic/Pharmacodynamic Profiles of Danofloxacin in Rabbits Infected With Salmonella typhimurium After Oral Administration.Emergence and selection of isoniazid and rifampin resistance in tuberculosis granulomas.Variation in fluoroquinolone pharmacodynamic parameter values among isolates of two bacterial pathogens of bovine respiratory disease.Biochanin a Enhances the Defense Against Infection Through AMPK/ULK1/mTOR-Mediated Autophagy and Extracellular Traps and Reversing SPI-1-Dependent Macrophage (MΦ) M2 PolarizationMechanism-Based Disease Progression Model Describing Host-Pathogen Interactions During the Pathogenesis of Acinetobacter baumannii PneumoniaEstimating treatment prolongation for persistent infections
P2860
Q26795605-92B24223-B501-4406-AF82-7E1097A76AC4Q26862297-5805A84E-FBDB-4F7E-A8B6-E6C63AB97A00Q28551361-4C2B1C8D-941D-47E3-8E73-DC3A04F30C80Q28552950-96015B08-73ED-4884-8858-84A2F09087B8Q28647309-DFFAD913-7BB2-434B-BD35-FB0644FE895BQ28655580-2879E143-E19F-461C-8216-7D768DB60098Q30393531-A9B10340-5114-4655-ACE6-37FFC69BAD39Q30580929-C2112615-F322-445B-9321-7B261BF19835Q30604367-F45EA1DC-473E-48FA-A3B7-E2FF2D66DE20Q34765528-24FFE11D-F0F6-4560-9F6F-64DD6ED950FEQ35236703-6580136C-96E4-4025-9E15-9E1E2C474B7BQ35819409-77BF681A-4032-4EBF-B13F-0F170685EC77Q35826386-D2E58667-2860-4663-84A6-ADA29F75C6EFQ35909861-102064B1-9572-4390-A44E-DA52078E99D6Q36270884-78418EAE-AE62-471D-B129-71315845F5B2Q36275612-0CA85961-4AA0-44D9-B433-8BD1C7ED0205Q36499980-B4B5CD70-15DD-4886-A017-77406D9A0282Q37466064-B3EB60EA-E546-4270-8187-60FCE7175DACQ38639087-901949BC-0C06-45C4-BFB5-9C215B7B8A38Q38778418-8E386564-8213-4A10-A189-0F9154865A7BQ38809377-03FFA540-089A-48B3-8150-1BADE3FDF7C8Q39140300-C8CEA431-6586-48F3-90C2-E5A1171D0F11Q39265442-58654026-0CC9-4E6D-92E8-D892E05FBCDEQ40145734-A3A632D5-589E-46A7-B666-D75D64102E3DQ42695844-3CE0DF39-0B1D-4AFF-92F9-BFF68E849FA6Q52590950-D7E0E788-3763-42AF-9C37-B9E6DDD90957Q54295384-886405B3-7682-497B-A839-442FF0F18895Q54947609-DE08AF49-C042-475B-910F-E4786561997FQ54996259-9C0C56D4-3FD3-4859-8292-5AABD30C1143Q55691613-BD7F2872-2F92-45D3-97E3-9FF2841E6B1AQ57113211-A401F6B7-7644-4512-ADB1-5F951173DA43Q58705274-07B4A631-AD97-4B3F-AAA8-BA642885FA93Q58792186-FCBE407B-2DCB-40A3-AB70-44DFB864B4A5
P2860
Exploring the collaboration between antibiotics and the immune response in the treatment of acute, self-limiting infections
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Exploring the collaboration be ...... cute, self-limiting infections
@ast
Exploring the collaboration be ...... cute, self-limiting infections
@en
type
label
Exploring the collaboration be ...... cute, self-limiting infections
@ast
Exploring the collaboration be ...... cute, self-limiting infections
@en
prefLabel
Exploring the collaboration be ...... cute, self-limiting infections
@ast
Exploring the collaboration be ...... cute, self-limiting infections
@en
P2860
P356
P1476
Exploring the collaboration be ...... cute, self-limiting infections
@en
P2093
Bruce R Levin
Peter Ankomah
P2860
P304
P356
10.1073/PNAS.1400352111
P407
P577
2014-05-19T00:00:00Z